Related references
Note: Only part of the references are listed.Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome
P. Corradini et al.
LEUKEMIA (2007)
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
Christoph Kahl et al.
BLOOD (2007)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies
P Corradini et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation
NH Russell et al.
BONE MARROW TRANSPLANTATION (2005)
Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-Hodgkin lymphoma
RM Dean et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients
RD Faulkner et al.
BLOOD (2004)
Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma
E Morris et al.
BLOOD (2004)
Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry
CO Freytes et al.
BLOOD (2004)
Nonmyeloablative allogeneic hematopoietic transplantation:: A promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation
MP Escalón et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Syngeneic hematopoietic stem-cell transplantation for Non-Hodgkin's lymphoma: A comparison with allogeneic and autologous transplantation - The lymphoma working committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation
PJ Bierman et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation
AJ Peniket et al.
BONE MARROW TRANSPLANTATION (2003)
Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma
O Paltiel et al.
BONE MARROW TRANSPLANTATION (2003)
Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant
LC Feinstein et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation
CMPW Mandigers et al.
BONE MARROW TRANSPLANTATION (2003)
Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation
SP Robinson et al.
BLOOD (2002)
The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation
DI Marks et al.
BLOOD (2002)
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
PA McSweeney et al.
BLOOD (2001)
Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma
CI Chen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: A case-matched study from the European bone marrow transplant registry
CD Williams et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy
AD Schimmer et al.
BONE MARROW TRANSPLANTATION (2000)
Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma
A Nagler et al.
BONE MARROW TRANSPLANTATION (2000)
Allogeneic bone marrow transplantation for lymphoma
PJ Bierman
BLOOD REVIEWS (2000)
Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation
A Nagler et al.
EXPERIMENTAL HEMATOLOGY (2000)
Second allogeneic transplantation after failure of first autologous transplantation
JP Radich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Share Paper
